<qa>  Phase 2a multicenter, multicenter, double-blind, placebo-controlled study toPhase 2a multicenter, randomized, double-blind, placebo-controlled study to assess the pharmacodynamics, efficacy, and safety of tetomilast in patients with emphysema. 